(Q46561665)

23 December 2017

title

Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients? (English)

1 reference

23 December 2017

1 reference

T Imamoto

1

1 reference

23 December 2017

H Suzuki

2

1 reference

23 December 2017

M Yano

3

1 reference

23 December 2017

K Kawamura

4

1 reference

23 December 2017

N Kamiya

5

1 reference

23 December 2017

K Araki

6

1 reference

23 December 2017

A Komiya

7

1 reference

23 December 2017

Y Naya

8

1 reference

23 December 2017

T Shiraishi

9

1 reference

23 December 2017

T Ichikawa

10

1 reference

23 December 2017

publication date

3 June 2008

1 reference

23 December 2017

Prostate Cancer and Prostatic Diseases

published in

1 reference

23 December 2017

volume

12

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

78-82

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/pcan.2008.35

exact match

0 references

cites work

What causes prostate cancer? A brief summary of the epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

STUDIES ON PROSTATIC CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Association between prostate cancer and serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

High-grade prostate cancer is associated with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Testosterone as a predictor of pathological stage in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Pretreatment serum level of testosterone as a prognostic factor in Japanese men with hormonally treated stage D2 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Elevated expression of inhibin alpha in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Is low serum free testosterone a marker for high grade prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Influence of radical prostatectomy on serum hormone levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Effects of prostatectomy on testicular androgenesis and serum levels of gonadotropins in mature albino rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.35

31 March 2020

Identifiers

DOI

10.1038/PCAN.2008.35

1 reference

23 December 2017

1 reference

23 December 2017